Category: ODD/BTA/FTA Status Region: North America · United States Company: Pfizer Inc

US FDA grants fast track designation to Pfizers ervogastat/clesacostat combination to treat NASH

US FDA grants fast track designation to Pfizers ervogastat/clesacostat combination to treat NASH
Pfizer Inc. announced the US Food and Drug Administration (FDA) has granted Fast Track designation to Pfizer

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!